Compound Detail
CHEMBL404495
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL404495 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BSSQWRSSNZFRMM-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
531.6
MW (Da)
6.17
ALogP
7
HBA
2
HBD
81.1
PSA (Ų)
0.24
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 7.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| Hepatocyte growth factor receptor CHEMBL3717 | IC50 | 7.46 | 7.215 | 35.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 25.0 | nM | 7.6 | Inhibition of GST tagged VEGFR2 expressed in Sf9 cells | 18434145 |
| Hepatocyte growth factor receptor | IC50 | = | 35.0 | nM | 7.46 | Inhibition of TPR-Met fusion protein assessed as Y1230-34-35 phosphorylation | 18434145 |
| Hepatocyte growth factor receptor | IC50 | = | 108.0 | nM | 6.97 | Inhibition of GST tagged c-Met expressed in Sf9 cells | 18434145 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18434145 | 10.1016/j.bmcl.2008.04.009 | Hepatocyte growth factor receptor | 2 |
| 18434145 | 10.1016/j.bmcl.2008.04.009 | Vascular endothelial growth factor receptor 2 | 1 |
Data from ChEMBL 36 via Core Engine